AI assistant
BIO-TECHNE Corp — Director's Dealing 2017
Oct 30, 2017
30718_dirs_2017-10-30_29a24776-eb1e-41cd-9dc7-cc58b4cc9b6b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2017-10-26
Reporting Person: Gavin Robert M. (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-10-26 | Restricted Stock Units | $ | A | 1949.00 | Acquired | Common Stock (1949.00) | Direct | |
| 2017-10-26 | Stock Options (Right to buy) | $125.05 | A | 10742.00 | Acquired | 2024-08-09 | Common Stock (10742.00) | Direct |
| 2017-10-26 | Stock Options (Right to buy) | $125.05 | A | 14323.00 | Acquired | 2024-08-09 | Common Stock (14323.00) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1667.00 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Units | $ | Common Stock (1500.00) | 1500.00 | Direct | |
| Restricted Stock Units | $ | Common Stock (2111.00) | 2111.00 | Direct | |
| Stock Option (Right to Buy) | $108.49 | 2022-08-07 | Common Stock (12500.00) | 12500.00 | Direct |
| Stock Option (Right to Buy) | $108.49 | 2022-08-07 | Common Stock (9375.00) | 9375.00 | Direct |
| Stock Option (Right to Buy) | $93.32 | 2021-07-31 | Common Stock (10000.00) | 10000.00 | Direct |
| Stock Option (Right to Buy) | $90.25 | 2021-11-30 | Common Stock (5000.00) | 5000.00 | Direct |
| Stock Options (Right to buy) | $106.59 | 2023-08-18 | Common Stock (13028.00) | 13028.00 | Direct |
| Stock Options (Right to buy) | $106.59 | 2023-08-18 | Common Stock (17371.00) | 17371.00 | Direct |
| Stock Options (Right to buy) | $93.32 | 2021-07-31 | Common Stock (16667.00) | 16667.00 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2: Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F3: Vests 3,580 shares on 8/9/2018 and 3,581 shares each on 8/9/2019, 8/9/2020, 8/9/2021.
F4: Each restricted stock unit represents a contingent right to receive one shares of Bio-Techne common stock.
F5: Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6: Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7: 3,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
F8: 2,500 shares vest on each of 7/31/15, 7/31/16, 7/31/17 and 7/31/18.
F9: 1,500 shares vest on each of 12/1/15, 12/1/16, 12/1/17 and 12/1/18.
F10: Vests 4,343 shares on each 8/18/2017, 8/18/2018 and 8/18/2019 and 4,342 shares on 8/18/2020
F11: Fully exercisable